Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis
This work was partly supported by FDA grant U01FD00745501. This article reflects the views of the authors and does not represent the views or policies of the FDA or US Department of Health and Human Services.
Authors
- Ju Nyeong Park (ORCID: https://orcid.org/0000-0001-6490-9887)
- Tse Yang Lim (ORCID: https://orcid.org/0000-0001-5084-0911)
- Erin J. Stringfellow (ORCID: https://orcid.org/0000-0002-2286-1448)
- Zeynep Hasgül (ORCID: https://orcid.org/0000-0002-8973-6916)
- Lukas Glos (ORCID: https://orcid.org/0000-0003-2584-4122)
- Reza Kazemi (ORCID: https://orcid.org/0000-0002-2433-0712)
- Mohammad S. Jalali (ORCID: https://orcid.org/0000-0001-6769-2732)
- Huiru Dong (ORCID: https://orcid.org/0009-0004-3556-1075)
Institutions
- United States Food and Drug Administration (US)
- Center for Drug Evaluation and Research (US)
- Center for Disease Dynamics, Economics & Policy (US)
- Harvard University (US)
- Brown University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- The Lancet Regional Health - Americas
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1016/j.lana.2024.100898
- Citations
- 14
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.60
Funders
- U.S. Department of Health and Human Services
- U.S. Food and Drug Administration